Group 1 - Yang Xu has emerged as a prominent leader in the hard technology venture capital sector, leveraging her industry insights and investment strategies [1] - In 2019, while at the New York Stock Exchange, she increased the market share in China from 22% to 90%, facilitating over $17 billion in financing for more than 30 leading companies in the Asia-Pacific region [1] - Yang Xu founded Buttonwood Capital in 2024, successfully raising $80 million for her first fund and leading a $53 million investment in Flexcompute [2] Group 2 - Yang Xu's experience at JPMorgan provided her with a systematic industry understanding and a rigorous financial analysis framework, essential for her subsequent investment career [3] - Her role at the New York Stock Exchange involved market expansion, client communication, and strategic support for companies, enhancing her entrepreneurial perspective [3] - Yang Xu emphasizes that the competitive advantage in technology lies in the ability to convert technology into long-term value, requiring continuous product refinement and operational synergy [5] Group 3 - Yang Xu faced significant challenges as the head of the NYSE's China division, including low market share and the impact of the COVID-19 pandemic, but proactively sought to build trust through her actions [4] - She views the IPO process as a critical milestone for companies, focusing on global expansion, brand building, and governance optimization [5] - Yang Xu aims to be defined as a "limitless person," continuously breaking boundaries and engaging deeply in various technical fields [6][7]

Financial Data and Key Metrics Changes - Total revenue for Q1 2025 grew by 0.3% year over year to $61.3 million [5][32] - Lymphedema business line revenue decreased by 3% year over year to $50.6 million, while airway clearance revenue increased by 22% to $10.7 million [5][32] - Gross margins increased by 290 basis points year over year, while adjusted EBITDA decreased by 125% year over year [5][32] Business Line Data and Key Metrics Changes - Lymphedema product sales decreased by $1.8 million or 3% to $50.6 million, while airway clearance product sales increased by $1.9 million or 22% to $10.7 million [32] - Sales headcount in the lymphedema business decreased from 280 to 264, but is expected to increase to over 300 by the end of 2025 [10][25] Market Data and Key Metrics Changes - The company is maintaining a strong number two position in the airway clearance market, with significant growth in the bronchiectasis market [16][84] - The company expects revenue in the second quarter to be in the range of $73 million to $76 million, with full-year revenue guidance revised to $309 million to $315 million [14][34] Company Strategy and Development Direction - The company is focused on three strategic priorities: improving access to care, expanding treatment options, and enhancing lifetime patient value [17][26] - Investments in technology and human capital are aimed at streamlining sales and order management processes, including the launch of a new Salesforce CRM module [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth potential despite short-term challenges related to sales vacancies and CRM implementation [13][38] - The company anticipates a return to growth in the lymphedema channel as sales optimization strategies take effect [25][70] Other Important Information - The company ended the quarter with $83.6 million in cash, reflecting a decrease due to stock buybacks and annual bonus payments [6][34] - The company is actively monitoring global trade policies and assessing potential tariff impacts on cost of goods sold, expecting a total impact of less than $5 million in 2025 [35][36] Q&A Session Summary Question: Revenue guidance assumptions for the year - Management discussed the importance of hiring speed and sales rep proficiency with the new CRM tool as key drivers for revenue guidance [42][44] Question: Growth expectations for 2026 - Management indicated that while they are not ready to comment on 2026, they expect to exit 2025 with more momentum than in the first half of the year [50][52] Question: Updates on Nimble product launch - Management reported strong adoption of Nimble, with no manufacturing challenges and positive feedback from the market [61][62] Question: Airway clearance business growth sustainability - Management attributed growth in the airway clearance business to strategic partnerships and product placement agreements with DMEs [81][84] Question: Rep productivity and CRM tool impact - Management explained that the new CRM tool is designed to enhance productivity and efficiency for sales reps, which is expected to improve overall performance [92][93]

Financial Data and Key Metrics Changes - Gross revenue for Q4 2024 was $113 million, a 22% increase year-over-year, while net revenue increased by 23% to $98.6 million [9] - Net income for the quarter rose to $5.9 million, or $0.34 per share, compared to a net loss of $7.7 million in the previous year [10] - Full year gross revenue reached $426.6 million, marking a 23% increase, with net revenue up 25% to $379.7 million [11] - Adjusted EBITDA for the year was $59.5 million, representing a 15.7% margin on net revenue, a 26.6% year-over-year increase [12] Business Line Data and Key Metrics Changes - Building infrastructure remained the largest market, contributing 51% of gross revenue, followed by commercial (23%), residential (18%), and municipal (10%) [13] - Organic growth of net revenue was 8.5% in Q4 and 13% for the year, with emerging markets leading the growth [15] Market Data and Key Metrics Changes - Transportation accounted for 21% of gross revenue, with two-thirds from public client engagements, while power, utilities, and energy represented 18% [14] - The backlog grew over 30% during 2024 to just under $400 million, with new orders in Q1 2025 exceeding $100 million [19] Company Strategy and Development Direction - The company made eight strategic acquisitions in 2024 to enter new geographies and expand service offerings, enhancing expertise in areas like bridge design and sustainability [6] - The focus for 2025 includes strategic investments in M&A, product line expansions, and technology tools to enhance service delivery and organic growth [25] Management's Comments on Operating Environment and Future Outlook - Management noted strong trends in transportation due to IIJA spending and minimal disruptions from federal funding cuts, maintaining a defensive business model [27] - The company anticipates continued growth in oil and gas and mining sectors, with a focus on renewable energy infrastructure [24] Other Important Information - The company repurchased $34 million of stock in 2024, indicating confidence in the value of its equity [18] - Cash flow from operating activities improved significantly, generating nearly $12 million in Q4 and over $24 million for the year [17] Q&A Session Summary Question: Impact of IIJA on transportation vertical - Management observed that IIJA spending is beginning to kick in, with no adverse impacts noted [31] Question: Backlog comparison to past years - Backlog characteristics remain similar to previous years, with steady work contracted and authorized to proceed [33] Question: Investments in service line expansions and technology tools - The company is building a team to implement technology investments that enhance customer engagement and service delivery [37] Question: New orders and verticals driving growth - New orders in Q1 2025 are strong across all markets, with no single market overshadowing others [44][50] Question: Capital allocation strategy - The company is balancing M&A opportunities with stock buybacks and technology investments, assessing the best allocation of capital regularly [55] Question: Progress on gaining wallet share - The company is focusing on increasing geospatial capacity and getting involved earlier in project life cycles to enhance wallet share [62] Question: Update on natural gas pipeline replacement opportunities - The natural gas pipeline market remains active, providing significant recurring revenue [68] Question: Land development business in the D.C. area - The company has diversified significantly, with the D.C. area representing a low single-digit percentage of the overall portfolio [79]